Morningstar

Shanrong Biotechnology Corp SRBT

Stock OTCM

$0.00 0.00 (0.00%)

View Full Chart

As of Mar 25, 2026, 4:44:46 PM Delayed Price Closed

Trading Information

Previous Close Price: $0.00
Day Range: $0.00–0.00
52-Week Range: $0.00–0.34
Bid/Ask: $0.05 / $0.19
Shares Outstanding: 1.00B
Market Cap: $100,048.49
Volume/Avg: 825 / 825

Key Statistics

Price/Earnings (Normalized): —
Price/Sales: —
Dividend Yield (Trailing): 0.00%
Dividend Yield (Forward): 0.00%
Dividend Payment Schedule: —
Total Yield: —

Company Profile

Shanrong Biotechnology Corp Is a holding company for select biotechnology, health, and wellness operations.

Sector: Financial Services
Industry: Shell Companies
Stock Style Box: —
Total Number of Employees: 3
Website: https://www.srbtmerger.com

Valuation

Metric	SRBT
Price/Earnings (Normalized)	—
Price/Book Value	—
Price/Sales	—
Price/Cash Flow	—

Price/Earnings

No chart available

Financial Strength

Metric	SRBT
Quick Ratio	0.03
Current Ratio	0.03
Interest Coverage	−17.79

Quick Ratio

No chart available

Profitability

Metric	SRBT
Return on Assets (Normalized)	—
Return on Equity (Normalized)	—
Return on Invested Capital (Normalized)	—

Return on Assets

No chart available

Shell Companies Industry Comparables

Screen With Investor

1-Day Chart	Name	Price	Morningstar Rating for Stocks	Capital Allocation	Economic Moat	Market Cap
	Vylor Inc VYLR			LOCK\|?&G%WQd&	LOCK\|@SP	$50B
	Drugs Made In America Acquisition II Corp DMII			—	LOCK\|Qbj$	$649M
	EQV Ventures Acquisition Corp II Class A EVAC			—	LOCK\|@!K>$	$604M
	Bain Capital GSS Investment Corp Class A BCSS			—	LOCK\|LN>^K	$596M
	Cantor Equity Partners IV Inc Ordinary Shares - Class A CEPF			—	LOCK\|F<nJ	$588M
	Churchill Capital Corp XII Class A CXII			—	LOCK\|^fc	$574M
	Churchill Capital Corp XI Common shares class A CCXI			—	LOCK\|#^$	$571M
	American Exceptionalism Acquisition Corp A Ordinary Shares-Class A AEXA			—	LOCK\|@P?V^	$530M
	New America Acquisition I Corp Class A NWAX			—	LOCK\|%$sx	$499M
	Ares Acquisition Corp III Class A AAC			—	LOCK\|#wN^	$492M

Sponsor Center

Transparency is our policy. Learn how it impacts everything we do

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.

© Copyright 2026 Morningstar, Inc. All rights reserved. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.